TITLE

Association between smoking and chronic kidney disease: a case control study

AUTHOR(S)
Yacoub, Rabi; Habib, Habib; Lahdo, Ayham; Ali, Radwan Al; Varjabedian, Leon; Atalla, George; Akl, Nader Kassis; Aldakheel, Saleem; Alahdab, Saeed; Albitar, Sami
PUB. DATE
January 2010
SOURCE
BMC Public Health;2010, Vol. 10, p731
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
Background: The progression of chronic kidney disease (CKD) remains one of the main challenges in clinical nephrology. Therefore, identifying the pathophysiological mechanisms and the independent preventable risk factors helps in decreasing the number of patients suffering end stage renal disease and slowing its progression. Methods: Smoking data was analyzed in patients with CKD throughout 2005-2009. One hundred and ninety-eight patients who had recently been diagnosed with stage three CKD or higher according to the National Kidney Foundation (NKF) 2002 Classification were studied. The control group was randomly selected and then matched with the case subjects using a computerized randomization technique. The relative risk was estimated by computing odds ratio (OR) by using multinomial logistic regression in SPSS ® for Windows between the two groups. Results: Smoking significantly increases the risk of CKD (OR = 1.6, p = 0.009, 95% CI = 1.12-2.29). When compared to nonsmokers, current smokers have an increased risk of having CKD (OR = 1.63 p = 0.02, 95% CI = 1.08-2.45), while former smokers did not have a statistically significant difference. The risk increased with high cumulative quantity (OR among smokers with > 30 pack-years was 2.6, p = 0.00, 95% CI = 1.53-4.41). Smoking increased the risk of CKD the most for those classified as hypertensive nephropathy (OR = 2.85, p = 0.01, 95% CI = 1.27-6.39) and diabetic nephropathy (2.24, p = 0.005, 95% CI = 1.27-3.96). No statistically significant difference in risk was found for glomerulonephritis patients or any other causes. Conclusion: This study suggests that heavy cigarette smoking increases the risk of CKD overall and particularly for CKD classified as hypertensive nephropathy and diabetic nephropathy.
ACCESSION #
57223577

 

Related Articles

  • Calciphylaxis in pediatric end-stage renal disease. Imam, Abubakr A.; Mattoo, Tej K.; Kapur, Gaurav; Bloom, David A.; Valentini, Rudolph P. // Pediatric Nephrology;Dec2005, Vol. 20 Issue 12, p1776 

    Calciphylaxis is a rare, but life-threatening complication of end-stage renal disease (ESRD) that has been reported mostly in adult patients. The exact etiology is unknown, but the disease is commonly associated with a high calcium-phosphorus product and elevated levels of parathyroid hormone...

  • Big-head disease: Uremic leontiasis ossea. Kumar, S.; Thuraisingham, R.; Yaqoob, M. // Kidney International;May2006, Vol. 69 Issue 10, p1709 

    The article presents a nephrology image of the big-head disease, uremic leontiasis ossea. The patient is a 46-year-old woman with known epilepsy, on long-term phenobarbitone therapy and who developed end-stage renal failure. A photograph of her, showing bulging of malar bones and widening of...

  • Progression of kidney disease: Blocking leukocyte recruitment with chemokine receptor CCR1 antagonists. Anders, H. -J.; Ninichuk, V.; Schlöndorff, D. // Kidney International;Jan2006, Vol. 69 Issue 1, p29 

    Chronic kidney disease (CKD) is usually associated with interstitial leukocytic cell infiltrates, which may contribute to disease progression by production of proinflammatory, proapoptotic, and profibrotic mediators. Recruiting leukocytes into the kidney involves local expression of chemotactic...

  • Role of CX3C-chemokine CX3C-L/fractalkine expression in a model of slowly progressive renal failure. Koziolek, Michael J.; Müller, Gerhard-Anton; Zapf, Antonia; Patschan, Daniel; Schmid, Holger; Cohen, Clemens D.; Koschnick, Stefan; Vasko, Radovan; Bramlage, Carsten; Strutz, Frank // Nephrology Dialysis Transplantation;Mar2010, Vol. 25 Issue 3, p684 

    Background. The chemokine/chemokine receptor pair CX3C-L/CX3C-R is suspected to play a role in renal fibrogenesis. The aim of this study was to investigate their function in an animal model of slowly progressive chronic renal failure.

  • Long-term effects of a new ketoacid-amino acid supplement in patients with chronic renal failure. Mitch, William E.; Abras, Elias; Walser, Mackenzie // Kidney International;Jul1982, Vol. 22 Issue 1, p48 

    Nine patients with severe chronic renal failure (mean glomerular filtration rate 4.8 ml/min; mean serum creatinine 11.3 mg/dl) who were previously on a protein-restricted diet were treated with a diet containing an average of 33 kcal/kg and 22.5 g/day of mixed quality protein, supplemented by a...

  • Nutrition and the Pediatric Patient with CKD. Terrill, Cynthia J. // Nephrology Nursing Journal;Jan/Feb2007, Vol. 34 Issue 1, p89 

    The article discusses the nutrition of patients with chronic kidney disease. The article discusses the barriers to achieving the nutritional goals for renal patients. The things to consider in assessing the nutritional status and needs of renal patients are mentioned. The challenges encountered...

  • Bias in selecting treatment for end-stage renal disease. Porter, George A.; Lawson, Lorabeth; Buss, James // Kidney International Supplement;Dec1985, Issue 17, pS34 

    Evaluates the factors that influence the mode of treatment chosen by patients with end-stage renal disease. Number of patients enrolled in the study; Identification of treatment modes for the categorization of patients with end-stage renal disease; Response of patients to different mode of...

  • Hemoglobin variability related to increased risk for death.  // Hem/Onc Today;1/1/2008, Vol. 9 Issue 1, p44 

    The article discusses research being done on hemoglobin variability and mortality in end-stage renal disease (ESRD). It references a study by W. Yang et al, published in the 2007 issue of the "Journal of the American Society of Nephrology." The researchers concluded that a greater hemoglobin...

  • Chapter 16. Management of CKD.  // Clinical & Experimental Nephrology;Jun2009, Vol. 13 Issue 3, p226 

    The article explores issues related to the management of chronic kidney disease (CKD). The basic aim of CKD management is to block CKD or retard its progression to end-stage kidney disease (ESKD), which reduces the quality of life of CKD patients. Management of ESKD needs relatively costly renal...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics